Prof Franco Locatelli talks to ecancer at the ALL Assembly 2018 Meeting in Amsterdam about the novel therapies for paediatric B-ALL.
Prof Locatelli explains that immunotherapy in particular has several outstanding approaches that can really impact the natural course of the disease.
He adds we should not overlook the great results obtained using chemotherapy but there is still a great need to develop new therapies due to reaching a ceiling with chemotherapy intensity.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.